These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Design of gem-difluoro-bis-tetrahydrofuran as P2 ligand for HIV-1 protease inhibitors to improve brain penetration: synthesis, X-ray studies, and biological evaluation. Ghosh AK, Yashchuk S, Mizuno A, Chakraborty N, Agniswamy J, Wang YF, Aoki M, Gomez PM, Amano M, Weber IT, Mitsuya H. ChemMedChem; 2015 Jan; 10(1):107-15. PubMed ID: 25336073 [Abstract] [Full Text] [Related]
6. Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural Analysis. Ghosh AK, R Nyalapatla P, Kovela S, Rao KV, Brindisi M, Osswald HL, Amano M, Aoki M, Agniswamy J, Wang YF, Weber IT, Mitsuya H. J Med Chem; 2018 May 24; 61(10):4561-4577. PubMed ID: 29763303 [Abstract] [Full Text] [Related]
8. Design, synthesis, biological evaluation and X-ray structural studies of HIV-1 protease inhibitors containing substituted fused-tetrahydropyranyl tetrahydrofuran as P2-ligands. Ghosh AK, Martyr CD, Kassekert LA, Nyalapatla PR, Steffey M, Agniswamy J, Wang YF, Weber IT, Amano M, Mitsuya H. Org Biomol Chem; 2015 Dec 28; 13(48):11607-21. PubMed ID: 26462551 [Abstract] [Full Text] [Related]
9. Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2'-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex. Oscarsson K, Lahmann M, Lindberg J, Kangasmetsä J, Unge T, Oscarson S, Hallberg A, Samuelsson B. Bioorg Med Chem; 2003 Mar 20; 11(6):1107-15. PubMed ID: 12614898 [Abstract] [Full Text] [Related]
15. Design and synthesis of potent HIV-1 protease inhibitors with (S)-tetrahydrofuran-tertiary amine-acetamide as P2-ligand: Structure-activity studies and biological evaluation. Bai X, Yang Z, Zhu M, Dong B, Zhou L, Zhang G, Wang J, Wang Y. Eur J Med Chem; 2017 Sep 08; 137():30-44. PubMed ID: 28554091 [Abstract] [Full Text] [Related]
16. Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants. Ghosh AK, Rao KV, Nyalapatla PR, Osswald HL, Martyr CD, Aoki M, Hayashi H, Agniswamy J, Wang YF, Bulut H, Das D, Weber IT, Mitsuya H. J Med Chem; 2017 May 25; 60(10):4267-4278. PubMed ID: 28418652 [Abstract] [Full Text] [Related]